Navigation Links
SPO Medical Reports Nine Month Period Ending September 2008
Date:11/20/2008

NEW YORK, November 20 /PRNewswire-FirstCall/ -- SPO Medical Inc. (OTC: SPOM - News), a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices, announced its results for the nine-month period ended September 30, 2008.

Despite the continued deterioration in the macro-economic environment, gross revenues for the nine month period were US$2,421,000; declines in sales were mainly due to the lower sales in the US homecare market, which have been adversely affected by the current financial crisis. Sales of medical product have grown in areas outside the US, specifically in the Asian-Pacific marketplace.

During the third quarter of 2008, the Company continued to focus efforts in the medical market with its PulseOx 6000(TM) and PulseOx 6100(TM) lines for professional healthcare establishments and are currently involved in several tenders with these products. Additional commercial ventures are being sought via private labeling opportunities of the medical PulseOx product line. The Company believes that that this strategy will help realign revenue potentials.

Most recently, the Company has achieved significant technological progress with its non-medical market opportunities specifically with the baby monitor product line. We have developed a unique substrate for mounting the optical sensors and associated electronic components, which are combined to form a practical and durable baby ankle bracelet. This critical component will be entering limited field trials so that the baby monitor can commence further comprehensive market testing during 2009. The Company has plans to extend its non-medical product offering to include additional consumer mass-market applications using its proprietary reflective pulse-oximetry technology and is currently in discussion with several international organizations for marketing cooperation's in this regard.

Michael Braun
'/>"/>

SOURCE SPO Medical Inc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. China Medical Technologies Completes the Development of EGFR Molecular Diagnostic Kits
2. Serica Technologies Receives ISO Certification, Meets International Standards for Medical Device Manufacturing
3. PharmAthene Signs Agreement with Medison Pharma Ltd. to Commercialize and Distribute Biodefense Medical Countermeasures in Israel
4. Cleveland Clinic Recognizes New Strategies for Creating Vaccines for Avian Flu as a Top Ten Medical Innovation for 2009
5. Voler Expands Medical Device Design Capabilities
6. China Sky One Medical, Inc. Obtains Production Rights for Nine New Drugs
7. SpineSmith Partners Collaborates with University of Texas Biomedical Engineering Students to Develop Innovative Products
8. Cleveland Clinic Recognizes Circulating Tumor Cell Technology as Top Medical Innovation for 2009
9. Perry Baromedical Corporation Exhibiting at MEDICA 2008
10. Ohio Becoming Global Hub for Biomedical Research and Commercialization
11. China Medical Technologies Receives SFDA Approval for Breast Cancer HER-2 FISH Probe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... Inc. (NASDAQ: GNVC ) today announced the retirement ... of directors effective on October 24, 2014.   Dr. Horovitz joined ... chairman from June 2006 to November 2013.  During his tenure, ... Audit Committees of the board.  "We deeply ... to GenVec, and its stockholders," said Wayne T. Hockmeyer ...
(Date:10/20/2014)... Local veterinary surgeon, Dr. Tim McCarthy ... of donor stem cells for dogs with osteoarthritis. Dr. ... has performed clinical stem cell therapy for 7 years. ... if a single injection of donor stem cells into ... pain and inflammation in the treated joints. , ...
(Date:10/19/2014)... 19, 2014 The Asia-Pacific Bromine ... in Asia-Pacific with analysis and forecast of revenue. ... Pacific Bromine Market report, to get an idea ... a glimpse of the segmentation in the Asia-Pacific ... and figures. , http://www.micromarketmonitor.com/market/asia-pacific-bromine-6741503144.html , ...
(Date:10/19/2014)... 19, 2014 The Asian Orthopedic braces and ... Asia with analysis and forecast of revenue. The Orthopedic braces ... to around $416.5 million by 2018, at a developing CAGR ... TOC of the Asian Orthopedic braces and support systems market, ... also provides a glimpse of the segmentation of orthopedic braces ...
Breaking Biology Technology:Zola P. Horovitz To Retire From GenVec Board 2Cascade Veterinary Referral Center Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2The Asia-Pacific Bromine Market is estimated to grow to $4,080.1 million by 2018 - New Report by MicroMarket Monitor 2The Asia-Pacific Bromine Market is estimated to grow to $4,080.1 million by 2018 - New Report by MicroMarket Monitor 3The Asian Orthopedic braces and support systems market is estimated to grow to around $416.5 million by 2018 - New Report by MicroMarket Monitor 2The Asian Orthopedic braces and support systems market is estimated to grow to around $416.5 million by 2018 - New Report by MicroMarket Monitor 3The Asian Orthopedic braces and support systems market is estimated to grow to around $416.5 million by 2018 - New Report by MicroMarket Monitor 4
... Oberon FMR, Inc. was selected as the most promising ... Showcase Competition. Oberon, which uses a proprietary process ... a protein-rich ingredient for animal feed, was given top ... consisting of five venture capitalists: one from the sponsoring ...
... CLARA, Calif., Dec. 8 Align Technology,Inc. (Nasdaq: ... regulatory approval,from the Japanese Ministry of Health, Labour and ... and promotion of Invisalign in Japan, where,it has trained ... October, 2005. , ...
... Dec. 8 U.S. Pharmacopeia (USP) Convention,an official ... sold in the United States, on December 4, ... overall MEDMARX,reporting program to Quantros. This announcement ... strategic partnership wherein Quantros assumed all,operations, support, marketing ...
Cached Biology Technology:Oberon FMR Wins Top Prize at BioWest 2008 Venture Showcase Competition 2Oberon FMR Wins Top Prize at BioWest 2008 Venture Showcase Competition 3Oberon FMR Wins Top Prize at BioWest 2008 Venture Showcase Competition 4Oberon FMR Wins Top Prize at BioWest 2008 Venture Showcase Competition 5Align Technology Receives Expanded Regulatory Approval in Japan 2Quantros Acquires MEDMARX(R) from United States Pharmacopeia (USP) 2Quantros Acquires MEDMARX(R) from United States Pharmacopeia (USP) 3Quantros Acquires MEDMARX(R) from United States Pharmacopeia (USP) 4
(Date:10/22/2014)... Aware, Inc. (NASDAQ: AWRE ), a ... results for its third quarter ended September 30, 2014. ... million, an increase of 40% compared to $4.3 million in ... quarter of 2014 was $4.1 million compared to $1.0 million ... the current three month period was primarily due to: i) ...
(Date:10/18/2014)... suspected genetic conditions, a certain type of exome sequencing ... than traditional molecular diagnostic methods, according to a study ... released to coincide with the American Society of Human ... protein­coding region of the genome (the complete set of ... organism), has been rapidly applied in research settings and ...
(Date:10/17/2014)... is available in German . ... very few drugs. When treating overdoses, doctors are often limited ... difficult if there is a combination of drugs involved. So ... accidentally swallows his grandmother,s pills? ETH professor Jean-Christophe Leroux from ... find an answer to this question. "The task was to ...
Breaking Biology News(10 mins):Aware, Inc. Reports Third Quarter 2014 Financial Results 2Aware, Inc. Reports Third Quarter 2014 Financial Results 3Aware, Inc. Reports Third Quarter 2014 Financial Results 4Aware, Inc. Reports Third Quarter 2014 Financial Results 5Aware, Inc. Reports Third Quarter 2014 Financial Results 6Aware, Inc. Reports Third Quarter 2014 Financial Results 7Study examines type of exome sequencing and molecular diagnostic yield 2Study examines type of exome sequencing and molecular diagnostic yield 3Emergency aid for overdoses 2Emergency aid for overdoses 3
... This news release is available in French . ... by inducing lesions in the DNA of tumour cells in order ... these lesions, and thus reduces the efficacy of chemotherapy. Blocking the ... the resistance of cells to treatment. A team of researchers directed ...
... orchestrated by a spectrum of signals from hormones within ... cytokinins originate in the roots of plants, and their ... leaves stimulates plant development. Though these phytohormones have been ... their transportation within plants was previously poorly understood. ...
... for fresh fruits and vegetables are associated with higher ... and middle-income households, according to American University researchers in ... small, but significant, association between the prices of fruit ... the study,s lead author and assistant professor of public ...
Cached Biology News:Enhancement of chemotherapy by prevention of tumor cell repair 2Roots to shoots: Hormone transport in plants deciphered 2High cost of fruits, vegetables linked to higher body fat in young children 2
A camera based compact unit for high speed scanning of 2D barcoded tubes in a cluster rack. This reader has been designed to read both 96 and 48 tube rack configurations and be compatible with common...
... The inductive drives of VARIOMAG Magnetic Stirrers ... motors, belts, or mechanical bearings, making VARIOMAG ... addition, the VARIOMAG inductive drive can be ... dust or microorganisms. This is why VARIOMAG ...
PTFE/red rubber septum silver aluminum seal ,11 mm seal diam. ...
...
Biology Products: